This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
MIT event, moderated by Lan Guan, CAIO at Accenture Accenture “98% of business leaders say they want to adopt AI, right, but a lot of them just don’t know how to do it,” claimed Guan, who is currently working with a large airliner in Saudi Arabia, a large pharmaceutical company, and a high-tech company to implement generative AI blueprints in-house.
M/CI plays a significant role in the decision making process of leading life science companies across all areas of the industry - including the pharmaceutical, biotechnology, and medical device sectors. The top life science companies work extensively with a network of external market and competitive intelligence (M/CI) vendors.
“It’s a win-win when you can get the long-term vision and growth of a company tied to individual career and professional development,” says Mark Yunger, vice president, head of IT at Servier Pharmaceuticals. From an individual’s perspective, it keeps careers interesting and helps people grow with the organization.
With more than 30,000 employees spread across more than 60 affiliate locations and 14 manufacturing sites around the world, pharmaceutical company Eli Lilly operates at a truly global scale. Operating at that scale comes with issues, not the least of which is sharing accurate and timely information internally and externally.
After the creation of Towa International in 2020 as part of the acquisition process of Pensa Pharma by Japan-based parent company Towa Pharmaceutical, Remuzgo decided to deconstruct the conception of the IT function, and rebuild it. “A The objective was to consolidate functions and become a new player in the pharmaceutical industry.
And while analysts expect a somewhat swift resolution to the work stoppage, “CIOs need to stay tuned into what’s happening around the globe and be thoughtful how it might affect their ability to operate,” said Bob McCowan, CIO at Regeneron Pharmaceuticals. Nate Melby, CIO of Dairyland Power Cooperative in Lacrosse, Wisc.,
The pharmaceutical industry is a highly regulated one, especially for multinationals doing business across the globe. Merck Life Sciences, a leading chemical and pharmaceutical company, with 60,000 employees working across 66 countries, was one of them. Dependency on human resources is both time-consuming and fraught with errors.
As an example, the technology organization of the pharmaceutical segment at Cardinal Health collaborates closely with business leaders so they can identify current pain points and determine the right processes to automate, focusing on how these tools will improve the customer or employee experiences, says CIO Greg Boggs. “The
“If we want to beat competition in the pharmaceutical industry, we must make use of next generation of technologies such as cloud, big data, and analytics. However, skilled resources don’t want to shift from a metro to a smaller city as they tend to look at it as demotion,” says Jitender Mishra, CIO at pharmaceuticals company Akums Group.
The Royal Pharmaceutical Society announced that it has appointed Avril Chester as its new Chief Technology Officer. To share job news, or any other information which you feel may be relevant and interesting to the CIO UK community, please contact us here ! March 2022. Avril Chester.
The giant pharmaceutical chain had put its lakehouse in place to address just such challenges in its quest, to, as Guadagno puts it, “To get the right product in the right place for the right patient.”. These processes combine an understanding of customer behavior with the availability of pharmaceutical and retail inventory. “It
It’s also in the service business, operating its own cloud infrastructure for pharmaceutical firms, manufacturing, and others. Nvidia says its hardware, software, and services can cut early-stage drug discovery from months to weeks.
For pharmaceutical companies in the digital era, intense pressure to achieve medical miracles falls as much on the shoulders of CIOs as on lead scientists. When Bob McCowan was promoted to CIO at Regeneron Pharmaceuticals in 2018, he had previously run the data center infrastructure for the $81.5
The technology helps adopters in fields as diverse as finance, healthcare, retailing, hospitality, pharmaceuticals, automotive, aerospace, and manufacturing. Predictive analytics use cases Organizations today use predictive analytics in a virtually endless number of ways.
As the global COVID-19 pandemic was beginning to spread, the company, one of the world’s largest suppliers of pharmaceuticals, medical devices, and consumer packaged goods, needed to reduce costs, speed up tasks, and improve the accuracy of its core business operations. Generally, J&J prefers everything in billions.”
Get ready for an exhilarating adventure as we unravel the incredible story of GEA Group , a global leader in industrial engineering systems for the food, beverage, and pharmaceutical sectors.
Participants came from all areas of the life sciences industry, including the pharmaceutical, biotechnology, and medical device spaces, in addition to contract research organizations. The research was conducted with over 200 M/CI decision-makers working at global life science organizations across North America and Europe.
Participants came from all areas of the life sciences industry, including the pharmaceutical, biotechnology, and medical device spaces, in addition to contract research organizations. The research was conducted with over 200 M/CI decision-makers working at global life science organizations across North America and Europe.
Participants came from all areas of the life sciences industry, including the pharmaceutical, biotechnology, and medical device spaces, in addition to contract research organizations. The research was conducted with over 200 M/CI decision-makers working at global life science organizations across North America and Europe.
Participants came from all areas of the life sciences industry, including the pharmaceutical, biotechnology, and medical device spaces, in addition to contract research organizations. -- Article Continues Below --. Don't miss this live CI event! Register Today!
This may seem like a fairly structured area, but given what we know about unstructured data production, pharmaceutical research generates a lot more of it than you might realize. Collaboration Considerations.
Perhaps most important, Idorsia taps into Veeva’s evolving knowledge base, which encompasses data from other customers such as major pharmaceuticals giants Merck, Bayer, and Kronos, the CIO says. And that is a major gain for a startup — getting the know-how and experience of Veeva’s entire customer base, he says.
In time, it will also help us balance the financial realities of the pharmaceutical industry with the moral imperative to render aid where needed. Clinical trials and R&D in the pharmaceutical industry have reached what some call a crisis point. Artificial intelligence can help us take better care of those we’ve left behind.
Defined as quantifiable and objective behavioral and physiological data collected and measured by digital devices such as implantables, wearables, ingestibles, or portables, digital biomarkers enable pharmaceutical companies to conduct studies remotely without the need for a physical site.
“We have more than 100,000 associates in addition to externals working for us, and that’s quite a large user group to serve,” says Axel Goris, global visual analytics lead at Novartis, the multinational pharmaceutical corporation based in Basel, Switzerland. “A
This innovation not only ensures product freshness and authenticity, but boosts confidence among stakeholders in critical sectors like pharmaceuticals and food, where traceability is crucial for regulatory compliance.
That led me into a role in the pharmaceutical industry, again, building and operating processes to manufacture pharmaceuticals. From that point forward, I was fortunate enough to lead both the IT and OT teams within global pharmaceutical manufacturing and supply chain organizations.
In contrast, manufacturing-based industries, such as aerospace, automotive, and advanced electronics could experience less disruptive effects due to limitations of the new technology’s usage in these industries as most work requires physical labor, the report said.
For instance, the FDA had to go through large volumes of research and clinical trial data provided by pharmaceutical companies Pfizer, Moderna, and Johnson & Johnson to approve their Covid-19 vaccines.
Richard Petronzio has been working for Bayer Pharmaceuticals for more than six years and currently serves as senior director of business insights at the German company. Before joining Bayer Pharmaceuticals, he was with Platform Advisors, a division of The CDM Group, according to his LinkedIn profile. ArchIntel™ -.
Ryan Tohill is currently an associate director of global competitive intelligence for dermatology and rheumatology at The Janssen Pharmaceutical Companies of Johnson & Johnson, based in Horsham, Pennsylvania. He began his services for the pharmaceutical company as business analytics and forecasting manager based in London, England.
The developer productivity metrics that matter most The reason we believe this is that we are working with 20 tech, finance, and pharmaceutical companies that are doing it. So, it’s complicated. But we believe it can be done. The results are not definitive, but they are promising.
Cultivating visibility matters for a few reasons,” says Kathryn Guarini, a former IBM CIO and now a board member at Regeneron Pharmaceuticals. Kathryn Guarini, board member, Regeneron Pharmaceuticals, and former IBM CIO Guarini “You want to be the one considered for opportunities to have an impact,” she says.
He started out as a scientist, working his way up the research and development ranks in the pharmaceutical industry, an experience steeped in curiosity that has helped shape his emphasis on continuous learning to this day.
Understanding your competitors' strategies in today’s highly competitive pharmaceutical industry can give your brand a crucial edge. With the pharmaceutical and healthcare advertising market booming in the United States, leveraging competitive intelligence has never been more essential.
In a pharmaceutical company, AI can accelerate drug development through the identification of key proteins, or turbocharge drug design by speeding up the ability to generate complex molecular structures.
pharmaceutical industry in 2021 and beyond. The race to create new products against COVID-19 amid the emergence of new mutations is expected to eclipse every other effort in health care and pharmaceuticals this year. pharmaceutical and health care industry’s more notable CI executives. ArchIntel™ -.
Caveat emptor in the cloud Bob McGowan, CIO of Regeneron Pharmaceuticals, acknowledges the risk of cloud concentration is valid but he is more concerned about the readiness of SaaS partners. “If Here is a look at how CIOs view the nature and nuances of cloud concentration risks — and what many are doing to mitigate them.
This exercise will surface high-risk areas of the supply chain such as the auto industry’s overdependence on a few semiconductor factories in Taiwan, or the global pharmaceutical sectors’ reliance on Chinese supplies for foundational life science ingredients.
Companies like Recursion Pharmaceuticals and Generate:Biomedicines are developing foundation models for biology, indicating AI’s broad adoption in industries including automotive, healthcare, and financial services.
It consists of a vast network of interconnected entities, including hospitals, insurance providers, pharmaceutical companies, and government entities. Dynamic data collection practices can help healthcare organizations: Enhance Competitiveness. The modern healthcare system is incredibly complex.
The technology supports their work to help members embrace healthier lifestyles, avoid costly pharmaceuticals, recover faster from medical procedures and more. Healthcare companies already applying graph databases and graph analytics are experiencing the benefits.
Barcelona proves a perfect fit Lufthansa Group is joining a host of major business peers in powering up a digital hub in Barcelona, including fast-moving consumer goods makers Danone and Unilever, tech firm Dynatrace, and Roche in pharmaceuticals.
Competition is fierce in the pharmaceutical and healthcare industry. With dozens of companies competing to catch the attention of both patients and healthcare providers, it can be a challenge to differentiate your brand.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content